Drug Shortage Report for JAMP-RAMIPRIL
Report ID | 137042 |
Drug Identification Number | 02440334 |
Brand name | JAMP-RAMIPRIL |
Common or Proper name | Ramipril Capsules |
Company Name | JAMP PHARMA CORPORATION |
Market Status | DORMANT |
Active Ingredient(s) | RAMIPRIL |
Strength(s) | 15MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL ORAL |
Packaging size | 100 |
ATC code | C09AA |
ATC description | ACE INHIBITORS, PLAIN |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2020-10-01 |
Estimated end date | 2022-12-30 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2021-04-07 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2021-04-07 | French | Compare |
v1 | 2021-04-07 | English | Compare |
Showing 1 to 2 of 2